Saudi Journal of Kidney Diseases and Transplantation (Jan 2016)

Characteristics and outcome of living kidney donors after donation: A report from Cote d′Ivoire

  • Delphine Amélie Lagou,
  • Kan Clément Ackoundou-N′guessan,
  • Tchakam Léopold Njapom,
  • Yassongui Mamadou Sekongo,
  • Cyr Monley Guei,
  • Mélanie Weu Tia,
  • Daze Apollinaire Gnionsahe

DOI
https://doi.org/10.4103/1319-2442.182400
Journal volume & issue
Vol. 27, no. 3
pp. 563 – 568

Abstract

Read online

Kidney transplantation from living kidney donors (LKDs) because of its good results represents a good option for the treatment of patients with the end-stage renal disease. Kidney donation is a relatively safe procedure according to several studies. We conducted this cross-sectional study in order to describe the demographic, clinical, and renal outcome of LKD in Cτte d′Ivoire. From March to November 2014, LKD residing in Cτte d′Ivoire at the time of investigation and having donated the kidney more than one year ago were considered for the study. They were evaluated through a questionnaire. Of the 29 LKD listed in Cτte d′Ivoire, only 14 responded to the questionnaire. The mean age at donation was 43.29 ± 9.12 years (27-59) and 10 of the LKD were women. Eight were related to the recipients, and the remaining were spouses. Laparoscopic nephrectomy was performed in nine LKD. The left kidney was harvested in ten cases. The main motivation for donation in all donors was the desire to save a life. At the time of the survey, the average duration after the donation was 4.57 ± 2.56 years (1-8). Only five donors had a regular nephrological follow-up. Hypertension was observed in one donor, seven had significant proteinuria, and six had glomerular filtration rate 30 mL/min. Significantly higher proteinuria was noted in donors under 45 years as compared to those over 45 years (0.43 ± 0.17 g/24 h vs. 0.22 ± 0.03 g/24 h, P = 0.01). Our study suggests that renal disease in LKD in Cτte d′Ivoire is low after a mean follow-up period of four years. A donor registry is essential to ensure better follow-up of donors in order to detect potential adverse effects of kidney donation in the medium as well as in the long-term.